Company to present on Wednesday, January 15, 2020 at 10 am PT / 1 pm ET SUNNYVALE, Calif. , Jan. 13, 2020 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) will be discussing its business and revenue growth expectations for the next three fiscal years at the JP Morgan Healthcare Conference on
SUNNYVALE, Calif. , Jan. 16, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2019 on Tuesday, January 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
SUNNYVALE, Calif. , Jan. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2020 ended December 31, 2019 . Recent Company Highlights Gross orders of $98.6 million , including 11 orders from China Net orders of $89.9
SUNNYVALE, Calif. , Feb. 5, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy ® System in the treatment of advanced rectal cancer. Radiotherapy, with or without chemotherapy, followed by surgery is the
SUNNYVALE, Calif. , Feb. 25, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife ® M6™ System in Missouri at their state-of-the-art
SUNNYVALE, Calif. , March 5, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Michael Hoge , the company's new Senior Vice President, Global Operations. As a material inducement to Mr.
SUNNYVALE, Calif. , April 16, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2020 on Tuesday, April 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
SUNNYVALE, Calif. , April 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2020 ended March 31, 2020 . Recent Company Highlights Gross orders increased 27% year-over-year to $106.0 million , including 11 orders from
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies SUNNYVALE, Calif. , May 19, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that MedTech Breakthrough , an independent market intelligence organization that recognizes the top
Geisinger Wyoming Valley Medical Center is First in the World to Treat Patients with the New System SUNNYVALE, Calif. , June 17, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife ® S7™ System , an innovative device combining speed,
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
